AnalystsFaisal KhurshidFaisal Khurshid's Stock Forecasts
AnalystsFaisal Khurshid
Sectors:
Analyst Ranking
Top 16%
#801 out of 5208 analysts
Average Return
+39.2%
Win Rate
52%12 out of 23
Risk vs Reward
Poor
Good
Faisal Khurshid's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Shattuck Labs IncSTTK | +391.86% | $0.86 | $4.23 | 2025-08-14 - 2026-03-03 | Buy |
Shattuck Labs IncSTTK | +261.54% | $1.17 | $4.23 | 2025-03-16 - 2026-03-03 | Buy |
Spyre Therapeutics IncSYRE | +239.58% | $11.80 | $40.07 | 2025-04-07 - 2026-03-03 | Buy |
Trevi Therapeutics IncTRVI | +143.59% | $3.12 | $7.60 | 2024-09-08 - 2025-09-08 | Buy |
Kymera Therapeutics IncKYMR | +102.74% | $40.11 | $81.32 | 2024-12-26 - 2025-12-26 | Buy |
Faisal Khurshid Analyst Color
Get additional color on Faisal Khurshid's coverage of popular stocks
Faisal Khurshid's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 3 | Buy | $118.00 | +36.65% | Maintains | 3 months ago |
Trevi Therapeutics IncTRVI | 2 | Buy | $16.00 | +30.51% | Maintains | 3 months ago |
Abcellera Biologics IncABCL | 2 | Hold | $4.00 | +7.82% | Downgrades | 4 months ago |
Galapagos NvGLPG | 2 | Buy | $40.00 | +21.03% | Upgrades | 4 months ago |
Contineum Therapeutics IncCTNM | 1 | Buy | $20.00 | +41.84% | Initiates Coverage On | 5 months ago |
Atyr Pharma IncATYR | 2 | Hold | $1.00 | +4.17% | Downgrades | 6 months ago |
Protagonist Therapeutics IncPTGX | 1 | Buy | $73.00 | -20.04% | Initiates Coverage On | 6 months ago |
Shattuck Labs IncSTTK | 2 | Buy | $2.00 | -52.72% | Maintains | 7 months ago |
Rhythm Pharmaceuticals IncRYTM | 2 | Buy | $102.00 | +13.89% | Maintains | 8 months ago |
Ironwood Pharmaceuticals IncIRWD | 2 | Hold | $1.00 | -72.53% | Maintains | a year ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $45.00 | +12.30% | Initiates Coverage On | a year ago |
Nurix Therapeutics IncNRIX | 1 | Hold | $16.00 | +1.20% | Initiates Coverage On | a year ago |
Pliant Therapeutics IncPLRX | 2 | Hold | $2.00 | N/A | Downgrades | a year ago |
Ani Pharmaceuticals IncANIP | 1 | Buy | $80.00 | N/A | Initiates Coverage On | a year ago |
Zura Bio LtdZURA | 1 | Buy | $15.00 | N/A | Initiates Coverage On | a year ago |
Puretech Health PLCPRTC | 1 | Buy | $45.00 | N/A | Assumes | a year ago |
Geron CorpGERN | 1 | Buy | $7.00 | N/A | Initiates Coverage On | a year ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | N/A | Assumes | a year ago |
Immunic IncIMUX | 1 | Buy | $5.00 | N/A | Assumes | a year ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Rain Oncology IncRAIN2 | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.